肺炎支原体感染对小儿支气管哮喘急性发作的影响分析被引量：43

下载PDF

导出

摘要目的分析肺炎支原体感染对小儿支气管哮喘急性发作的影响。方法将80例支气管哮喘患儿作为研究组,同期选择80例普通感冒患儿作为对照组,对比两组支原体感染相关情况。同时根据哮喘分期将研究组患儿分为急性期(41例)及缓解期(39例),对比不同疾病分期间支原体感染相关情况。结果研究组支原体感染率明显高于对照组(P<0.05),同时,研究组支原体抗体滴度1∶320明显高于对照组(P<0.05)。而研究组急性期支原体感染率明显高于缓解期(P<0.05),且研究组急性期支原体抗体滴度1∶320明显高于缓解期(P<0.05)。在所观察的急性发作期患儿中,支原体抗体滴度与第一秒用力呼气容积(FEV1)及第一秒用力呼气容积占预计值百分比(FEV1%)均存在显著的正相关(P<0.05)。结论肺炎支原体感染易引起小儿支气管哮喘急性发作,在患儿发病早期可检测肺炎支原体抗体,以指导临床治疗。

作者郑敏斯高梅何德根欧彩香

机构地区广东省中山市中医院儿科

出处《检验医学与临床》 CAS 2016年第8期1083-1085,共3页 Laboratory Medicine and Clinic

基金广东省中山市医学科研项目(2014J077)

关键词肺炎支原体支气管哮喘急性发作儿童

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献11

1唐炜,金胜利,凌亚平.儿童支原体感染与支气管哮喘相关性分析[J].中国中西医结合儿科学,2012,4(3):236-237. 被引量：7
2Atkinson TP. Mycoplasma pneumoniae:does it have a role in asthma pathogenesis?[J]. Curr Pediatr Rev,2013,9(4):289-295.
3苏楠,林江涛,刘关键,马利军,邱晨,刘春涛,林燕萍,殷凯生,白春学,陈明伟,刘华,陈萍.我国各级医院医师对普通感冒认知与诊治现状的调查[J].中华内科杂志,2012,51(4):266-269. 被引量：17
4李经师.血清IL-10、IL-4及IgE在小儿支气管哮喘中的检测意义分析[J].中国实验诊断学,2014,18(2):234-235. 被引量：23
5李宾,吴福玲,冯学斌,韩兆东,李营营,石涛.呼吸道合胞病毒毛细支气管炎与支气管哮喘的相关性研究[J].临床儿科杂志,2012,30(2):116-119. 被引量：102
6张耀源,张孔.支气管哮喘患者血清白细胞介素35水平变化及意义[J].中山大学学报（医学科学版）,2012,33(3):398-401. 被引量：21
7Shah SS,Test M,Sheffler-Collins S,et al. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia [J]. J Hosp Med,2012,7(4):311-317.
8Chung HL,Shin JY, Ju M,et al. Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia[J]. Cytokine,2011,54(2):218-221.
9Lee KE, Kim KW, Hong JY, et al. Modulation of IL-8 boosted by Mycoplasma pneumoniae lysate in human airway epithelial cells [J], J Clin Immunol,2013,33(6):1117-1125.
10Narita M,Tanaka H. Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia [J]. Cytokine,2012,59(1):18-19.

二级参考文献58

1聂维华,张玉萍.2007年感冒药使用情况调查分析[J].实用医技杂志,2008,15(14):1825-1826. 被引量：4
2Jaffar Z,Sivakunu T,Roberts K.CD4+CD25+T cells regulateairway eosinophilic inflammation by modulating the Th2cell phenotype[J].J Immunol,2004,172(6):3842-3849.
3Scherf W,Burdach S,Hansen G.Reduced expression oftransforming growth factor beta 1 exacerbates pathology inan experimental asthma model[J].Eur J Immunol,2005,35(1):198-206.
4Bettelli E,Carrier Y,Gao W,et al.Reciprocal develop-mental pathways for the generation of pathogenic effectorTH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
5Lee JH,Yu HH,Wang LC,et al.The levels of CD4+CD25+regulatory T cells in paediatric patients with allergicrhinitis and bronchial asthma[J].Clin Exp Immunol,2007,148(1):53-63.
6Piippo-Savolainen E,Remes S,Kannisto S,et al.Asthmaand lung function 20 years after wheezing in infancy:results from a prospective follow-up study[J].Arch PediatrAdolesc Med,2004,158(11):1070-1076.
7Sigurs N.A cohort of children hospitalised with acute RSVbronchiolitis:impact on later respiratory disease[J].Pae-diatr Respir Rev,2002,3(3):177-183.
8Pala P,Bjarnason R,Sigurbergsson F,et al.EnhancedIL-4 responses in children with a history of respiratorysyncytial virus bronchiolitis in infancy[J].Eur Respir J,2002,20(2):376-382.
9Mailaparambil B,Grychtol R,Heinzmann A.Respiratorysyncytial virus bronchiolitis and asthma-insights fromrecent studies and implications for therapy[J].InflammAllergy Drug Targets,2009,8(3):202-207.
10Cautivo KM,Bueno SM,Cortes CM,et al.Efficient lungrecruitment of respiratory syncytial virus-specific Th1 cellsinduced by recombinant bacillus Calmette-Guérin promotesvirus clearance and protects from infection[J].J Immunol,2010,185(12):7633-7645.